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Previewstreatment of crude hemozoin extracts
ablates its TLR9-mediated immune-stimu-
latory activity, suggesting that hemozoin
itself maybe immunologically inert. In
fact, their data implicated hemozoin crys-
tals as just a ‘‘carrier’’ to deliver malaria
DNA to TLR9 expressed in phago-endo-
somes (Parroche et al., 2007).
Probably stimulated by these conflict-
ing conclusions, Coban et al. have now
further analyzed the mechanism by which
TLR9 activates innate immune cells
during malaria infection. In this issue of
Cell Host & Microbe, they first report
that the immunogenicity of whole-para-
site vaccines against P. falciparum
involves hemozoin as ligand for host
TLR9 (Coban et al., 2010). At the molec-
ular and atomic level, they go on to
show that DNA-free hemozoin not only
directly binds to TLR9, but also induces
conformational changes of TLR9 equal
to those induced by the canonical
TLR9 ligand CpG-DNA. Furthermore,
TLR9 binding of hemozoin requires the
same binding motifs as that of CpG
DNA. Altogether, these data unequivo-
cally resolve the ‘‘TLR9-hemozoin’’
controversy.
In addition, the in-depth analyses of
Coban et al. dug out some unexpected6 Cell Host & Microbe 7, January 21, 2010 ª2observations. In various vaccination
protocols, synthetic (s)-hemozoin medi-
ated its robust adjuvant effect via
MyD88, a scaffold protein of TLR sig-
naling, but did not require TLR9- or
PRR-driven inflammasome activation,
suggesting that natural hemozoin prefer-
entially activates TLR9, whereas s-hemo-
zoin drives an as yet undefined receptor
in a MyD88-dependent manner. Counter-
intuitively, a new receptor puzzle has thus
been generated.
While this existing set of data primarily
focuses on natural hemozoin and its func-
tion as a TLR9-dependent ‘‘built-in’’ adju-
vant during whole-blood stage parasite
vaccination, it also raises questions that
now can be addressed. Given that Tregs
presumably drive chronic malaria infec-
tion, it would be interesting to learn
whether the TLR9 ligand hemozoin also
triggers Treg formation. A real surprise
would be if the yet unknown hemozoin-
sensing receptor comes into play for
Treg formation.REFERENCES
Belkaid, Y., Piccirillo, C.A., Mendez, S., Shevach,
E.M., and Sacks, D.L. (2002). Nature 420, 502–
507.010 Elsevier Inc.Coban, C., Ishii, K.J., Kawai, T., Hemmi, H., Sato,
S., Uematsu, S., Yamamoto, M., Takeuchi, O.,
Itagaki, S., Kumar, N., Horii, T., and Akira, S.
(2005). J. Exp. Med. 201, 19–25.
Coban, C., Igari, Y., Yagi, M., Reimer, T., Koyama,
S., Aoshi, T., Ohata, K., Tsukui, T., Takeshita, F.,
Sakurai, K., et al. (2010). Cell Host Microbe 7,
this issue, 50–61.
Hisaeda,H.,Tetsutani, K., Imai,T.,Moriya,C.,Tu,L.,
Hamano, S., Duan, X., Chou, B., Ishida, H., Aramaki,
A., et al. (2008). J. Immunol. 180, 2496–2503.
Hisaeda, H., Maekawa, Y., Iwakawa, D., Okada,
H., Himeno, K., Kishihara, K., Tsukumo, S., and
Yasutomo, K. (2004). Nat. Med. 10, 29–30.
Jaramillo, M., Plante, I., Ouellet, N., Vandal, K.,
Tessier, P.A., and Olivier, M. (2004). J. Immunol.
172, 3101–3110.
Palm, N.W., and Medzhitov, R. (2009). Immunol.
Rev. 227, 221–233.
Parroche, P., Lauw, F.N., Goutagny, N., Latz, E.,
Monks, B.G., Visintin, A., Halmen, K.A., Lamphier,
M., Olivier, M., Bartholomeu, D.C., et al. (2007).
Proc. Natl. Acad. Sci. USA 104, 1919–1924.
Takeda, K., Kaisho, T., and Akira, S. (2003). Annu.
Rev. Immunol. 21, 335–376.
Walther, M., Tongren, J.E., Andrews, L., Korbel, D.,
King, E., Fletcher, H., Andersen, R.F., Bejon, P.,
Thompson, F., Dunachie, S.J., et al. (2005).
Immunity 23, 284–296.TB or not TB? Fishing for Molecules
Making Permissive GranulomasStefan Ehlers1,*
1Cluster of Excellence Inflammation-at-Interfaces, Microbial Inflammation Research, Research Center Borstel, Parkallee 1,
D-23845 Borstel, Germany
*Correspondence: sehlers@fz-borstel.de
DOI 10.1016/j.chom.2009.12.010
Focal accumulations of mononuclear cells, called granulomas, are a hallmark of mycobacterial infections.
A common misconception is that granulomas are uniformly protective. In transparent zebrafish larvae
infected with Mycobacterium marinum, Volkman et al. demonstrate an interaction of mycobacteria with
epithelial cells that helps recruit macrophages to the granuloma as ‘‘feeder cells.’’Mycobacterial infections rank among
the diseases with the highest morbidity
and mortality worldwide. Mycobacterium
tuberculosis complex (Mtb) alone causes
8 million new cases of tuberculosis(TB) each year, with 20% of those infected
succumbing to disease.
The pathological hallmark of TB is the
granuloma, a focal accumulation of mac-
rophages and lymphocytes in variousstages of differentiation. The tubercle
(from the Latin word ‘‘tuberculum,’’ a small
knob or nodule) harbors mycobacteria in
different phases of replication and meta-
bolic distress. Granulomas are the visible
Figure 1. Model of Early Molecular and Cellular Events
in Mycobacteria-Orchestrated Granuloma Formation
The Mycobacterium marinum-derived early secreted antigenic target of 6 kDa
(ESAT6) is released from Mm-infected macrophages or extracellular Mm
and induces in neighboring epithelial cells the secretion of matrix metallopro-
teinase 9 (MMP9). This results in activation of chemokine gradients and
extracellular matrix degradation, facilitating the migration of uninfected macro-
phages into the nascent granuloma. Thus, mycobacteria direct the early
accumulation of host cells that act as their preferred site of replication.
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Previewssigns of a dynamic immune
response and are the proto-
typic ‘‘double-edged sword.’’
The close juxtaposition of
Mtb-bearing macrophages
and macrophage-activating
lymphocytes affords myco-
bacterial growth arrest. How-
ever, granulomas displace
parenchymal tissue and may
necrotize or disintegrate,
thereby disrupting into
bronchi and allowing environ-
mental spread of Mtb. Disso-
ciating the mechanisms
governing antibacterial pro-
tection from that causing
tissue damage and mycobac-terial dissemination has been a ‘‘holy
grail’’ of TB research.
Granulomas induced during Mtb infec-
tion of mice, guinea pigs, rabbits, and
nonhuman primates all reflect distinct
features of granuloma immunopathology,
and all have their specific shortcomings.
The very early phase of innate responses
to infection may also be explored in
zebrafish larvae infected with a species
genetically related to Mtb, M. marinum
(Mm), the causative organism of fish
tank granuloma in humans. Mm grows
faster (visible colonies within 6 days) and
at a lower temperature (30C) than does
Mtb, but it shares a number of virulence
features with Mtb. Among them is the
genomic region of difference 1 (RD1)
that harbors a secretory system capable
of translocating proteins across the other-
wise impermeable mycobacterial cell
wall. One of them is ESAT6, which has
cytotoxic potential and is among the
earliest proteins recognized by the T cell
response (hence the name; early secre-
tory antigenic target of T cells of 6 kDa
size) (Andersen et al., 1995).
Zebrafish larvae are transparent, and
therefore cell migration, bacterial multipli-
cation, and bacterial dissemination may
be monitored with appropriate quantita-
tive real-time, intravital fluorescent mi-
croscopy techniques. Ramakrishnan and
colleagues have exploited the genetic
tractability and optical transparency of
zebrafish embryos to show that (1) macro-
phage migration to the injected Mm
inoculum is induced only by bacteria
carrying the RD1 locus, (2) mycobacterial
interactions with innate immune cells are
sufficient to induce granuloma formation,and (3) some newly infected macro-
phages egress from the primary granu-
loma, seeding distal granulomas to
disseminate infection (Davis and Ramak-
rishnan, 2009). In their most recent report
(Volkman et al., 2009), the group uncovers
ESAT6 as the critical molecule encoded
by the RD1 locus and introduces another
unexpected (p)layer to the system. Neigh-
boring epithelial cells are directly induced
by ESAT6 to secrete matrix metalloprotei-
nase (MMP)9 (Figure 1).
MMPs are endopeptidases that can
degrade components of the extracellular
matrix, such as collagen and proteogly-
cans (Parks et al., 2004). They can also
modify the function of chemokines,
thereby influencing leukocyte migration
and tissue remodeling. The exact sig-
naling pathway by which ESAT6 drives
MMP9 production remains elusive, but
Volkman et al. (2009) have excluded
MyD88- and TNF-dependent signaling in
this scenario. Ablation of MMP9 resulted
in significantly diminished immune cell
recruitment in Mm-infected zebrafish
larvae. This confirms previous experi-
ments in the mouse model of Mtb infec-
tion, in which neutralization of MMP9, or
the use of MMP9 KO mice, had demon-
strated a requirement for MMP9 in the
early recruitment of macrophages and
granuloma formation (Taylor et al., 2006).
Volkman et al. point out that MMP9 levels
are also high in TB patients with advanced
disease, making it a potentially useful
biomarker for disease progression.
Can findings in fish be extrapolated to
human TB disease? After all, Mm—
despite its genetic relationship—is not
Mtb, zebrafish have no lungs, experi-Cell Host & Microbe 7, January 2mental infection is by intrave-
nous injection rather than
aerosol inhalation, and granu-
lomas in zebrafish larvae are
formed exclusively by innate
immune cells and are not
under the activating influence
of T cells.
Tuberculosis develops in
distinct stages. Initially, my-
cobacteria are phagocytosed
by macrophages that support
their intracellular replication.
It is in the bacterium’s interest
to induce the accumulation of
quiescent macrophages to
further its own replication.
Granulomas form even in theabsence of specific immunity (for
example, in SCID mice) (Smith et al.,
1997). It is a common misconception
that granulomas, by their very existence,
‘‘wall off’’ mycobacteria; rather, they pro-
vide the fertile soil on which mycobacteria
thrive. This is because innate immunity
alone does not have much to offer in
terms of defending against TB (Reiling
et al., 2008). It is the T cell-mediated
activation of cells assembled in the gran-
uloma, via interferon g, tumor necrosis
factor, or granulysin, that is capable of
turning the granuloma into a weapon
against mycobacterial replication. The
purpose of the adaptive immune re-
sponse is therefore not necessarily to
make a granuloma, but to activate cells
within a granuloma for mycobacteriocidal
or -static function. Fascination with the
histomorphological appearance of the
granuloma, which, in humans, often
appears as a mycobacteria-laden macro-
phage center with a lymphocytic cuff and
fibrotic capsule, has sometimes obscured
this simple fact. The zebrafish model has
rightfully redirected attention to the
subversive power of the mycobacterium
to establish its granulomatous niche
within the host.
However, MMP-mediated degradation
of extracellular matrix may also permit
early dissemination of mycobacteria to
lymph nodes and even the spleen,
thereby accelerating the induction of
adaptive immunity and repressing myco-
bacterial growth (Taylor et al., 2006).
This scenario, well known in the mouse
model of Mtb infection, cannot easily be
investigated in the zebrafish embryo, in
which lymphocytes are not yet functional.1, 2010 ª2010 Elsevier Inc. 7
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PreviewsIt is therefore prudent to remember that, in
the investigation of any human disease,
model systems may only serve to dissect
the pathophysiological process that they
adequately mimic.
The concept that mycobacteria manip-
ulate their environment to further their
own propagation merits consideration
not only in early phases of the disease.
After all, Mtb needs an exit route from
the granuloma if it is to infect and multiply
in other human beings. Foamy macro-
phages have recently attracted attention
as potentially significant players in this
scenario. They represent exhausted and
lipid-laden cells that either give rise to
central caseation or may occasionally
escape from the granuloma to seed other
parts of the lung (Russell et al., 2009). It
has long been clear that bacterial lipids
have a significant role in shaping the tissue
response at the infection site. More specif-
ically, trehalose-dimycolate (TDM, tradi-
tionally called cord factor, a major compo-
nent of the mycobacterial cell wall), which
accumulates in necrotic regions of mouse
granulomas, is specifically recognized by
macrophages via the monocyte-inducible
C-type lectin (Mincle) (Ishikawa et al.,
2009). Necrosis as such may therefore
also occur as a consequence of Mtb-
derived factors interacting with innate
immune cells. Matrix metalloproteinases8 Cell Host & Microbe 7, January 21, 2010 ª2could additionally be involved in tissue
breakdown during granuloma disintegra-
tion, and therapeutic neutralization may
ameliorate tissue pathology and reduce
dissemination.
In humans, however, granuloma
necrosis is rare in the absence of a strong
T cell response; indeed, cavity formation
is the most tangible equivalent of de-
layed-type hypersensitivity, i.e., dysregu-
lated T cell-mediated hyperinflammation,
in a vulnerable organ such as the lung.
Considering the long coexistence of
humans with Mtb, it is possible that Mtb
has evolved to drive a particular type of
human immunopathology to deliver it
from the confines of the granuloma and
let it escape through the airways.
Although one might consider necrosis to
be the ultimate answer of the host to
arrest Mtb growth within the granuloma-
tous lesion, Mtb may actually contribute
to it by releasing soluble factors or cell
wall constituents that skew the immune
response for this type of tissue pathology.
Intriguingly, TH2 responses, superim-
posed upon TH1 immunity, have been
associated with a higher tendency toward
progressive pathology in human beings
and mice (Rook, 2007). It remains to be
seen whether analysis of the signaling
pathways involved can be successfully
explored in the zebrafish.010 Elsevier Inc.ACKNOWLEDGMENTS
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